Cyril Engmann, MD, FAAP

Senior Director - Quality and Program Impact, and Institutional Official

Dr. Cyril Engmann is Senior Director - Quality and Program Impact, and Institutional Official at PATH. As Senior Director, he serves as the Senior Leader accountable for providing deep scientific, medical, and public health expertise, operational excellence, oversight, and leadership across all divisions of PATH to strengthen organizational impact. As Institutional Official, he oversees all of PATH’s research and regulatory affairs, including the confidential institutional review and/or approval process of proposed research activities involving human subjects.

Prior to this, he was the Director of the Maternal, Newborn, Child Health and Nutrition (MNCHN) global program at PATH. In that role, he led a department of over 120 staff (physicians, public health practitioners, social scientists, nutritionists, economists, engineers and business, policy and communications experts) working on five continents across a diverse and complex portfolio of work spanning the value chain from research, education, policy and planning, programming, implementation science, monitoring and evaluation, market dynamics and technical assistance at global and national level. Prior to joining PATH in 2014, Cyril led the Bill and Melinda Gates Foundation Newborn Health Strategy where he designed and oversaw a portfolio of grants totaling $200M. He also remains an active, practicing physician and academic at the University of Washington Schools of Medicine & Public Health, Seattle, where he is Attending Neonatologist and Professor of Pediatrics and Global Health.

Widely regarded as a Global Leader in the field and with extensive experience in the research, policy, advocacy and program spheres, Dr. Engmann is credited with initiating and leadership roles on several global efforts adopted by all 194 signatory countries of the United Nations, including the Every Newborn Action Plan, the Nurturing Care for Early Childhood Development Framework, the Global Preterm Research Consortium and the Maternal immunization Consortium. He regularly educates and conducts briefings at the United States Congress on maternal, newborn, child health and nutrition–related challenges and solutions domestically and internationally, and chaired a consortium of academic and non-governmental organizations that advised the British Government on their global nutrition portfolio spend. He has led numerous health consultations and educational briefings with Ministries of Health of Ethiopia, India, Ghana, Bangladesh, Kenya, and South Africa among others. Domestically, he sits on the United States National Institute of Health Expert Panel that advises on all US-Government-sponsored COVID-19 Trials.

He has authored over 130 peer-reviewed publications and book chapters, abstracts and white papers and was lead author of the expert group who outlined what the next 20 years should look like for the field of Reproductive, Maternal, Newborn and Child Health, and in another publication, for maternal immunization. He is a frequent keynote speaker at major global conferences, and sits on numerous international strategic, policy, and scientific advisory boards and steering committees. Domestically, he serves on the Washington Research Foundation postdoctoral fellowship program. In addition to currently mentoring staff and faculty of academic and non-academic settings, he has taught and supervised generations of undergraduate, masters and doctoral-level public health students, and medical students, residents, and fellows in the USA and abroad. He has been an external examiner for the University of Queensland, Australia and Malawi College MPH programs and has practiced medicine in Asia, Africa, Europe, and North America. Cyril is a Board-Certified active pediatrician and neonatologist and Fellow of the American Academy of Pediatrics and the Society for Pediatric Research.

Cyril has dedicated his life to addressing social injustice, improving health, and combating health inequity. He is passionate about driving organizational impact through strategic, interdisciplinary, purpose-driven partnerships, and in utilizing data evidence to improve the human condition and put bold solutions into action.